Not applicableUnknownNCT05158712What this trial is testingGenetic Factors and Pheochromocytomas in Neoplasia Type 2Who this might be right forNeoplasiaPheochromocytoma Assistance Publique Hopitaux De Marseille 14
Large-scale testing (Phase 3)Study completedNCT00325104What this trial is testingCinacalcet to Treat Familial Primary HyperparathyroidismWho this might be right forHypercalcemiaFamilial Primary Hyperparathyroidism National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 25
Not applicableUnknownNCT06081270What this trial is testingProspective Study on Resistance-associated Mutations in Metastatic Lung CancerWho this might be right forLung Cancer University of Milano Bicocca 20
Large-scale testing (Phase 3)Study completedNCT03194893What this trial is testingA Rollover Study of Alectinib in Patients With Anaplastic Lymphoma Kinase (ALK)-Positive or Rearranged During Transfection (RET)-Positive CancerWho this might be right forNeoplasms Hoffmann-La Roche 50
Early research (Phase 1)Study completedNCT02727283What this trial is testingA Phase 1, Randomized, Placebo-Controlled, Ascending Cohort, Dose Escalation Study in Normal Healthy VolunteersWho this might be right forIrritable Bowel Syndrome GlaxoSmithKline 16
Testing effectiveness (Phase 2)Study completedNCT03037385What this trial is testingPhase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid TumorsWho this might be right forRET-altered Non Small Cell Lung CancerMedullary Thyroid CancerRET-altered Papillary Thyroid Cancer+37 more Hoffmann-La Roche 590
Early research (Phase 1)Study completedNCT03780517What this trial is testingSafety, Efficacy, and Tolerability of BOS172738 in Patients With Advanced Rearranged During Transfection (RET) Gene-Altered TumorsWho this might be right forAdvanced Nonhaematologic Malignancies Boston Pharmaceuticals 117
Testing effectiveness (Phase 2)Study completedNCT00390325What this trial is testingSorafenib Tosylate in Treating Patients With Metastatic, Locally Advanced, or Recurrent Medullary Thyroid CancerWho this might be right forHereditary Thyroid Gland Medullary CarcinomaLocally Advanced Thyroid Gland Medullary CarcinomaMultiple Endocrine Neoplasia Type 2A+8 more National Cancer Institute (NCI) 21
Not applicableActive Not RecruitingNCT03655223What this trial is testingEarly Check: Expanded Screening in NewbornsWho this might be right forSpinal Muscular AtrophyFragile X SyndromeFragile X - Premutation+182 more RTI International 30,000
Not applicableLooking for participantsNCT01793168What this trial is testingRare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at SanfordWho this might be right forRare DisordersUndiagnosed DisordersDisorders of Unknown Prevalence+340 more Sanford Health 20,000
Testing effectiveness (Phase 2)Study completedNCT00514046What this trial is testingVandetanib to Treat Children and Adolescents With Medullary Thyroid CancerWho this might be right forMedullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2AMultiple Endocrine Neoplasia Type 2B National Cancer Institute (NCI) 17
Not applicableLooking for participantsNCT03050268What this trial is testingFamilial Investigations of Childhood Cancer PredispositionWho this might be right forAcute LeukemiaAdenomatous PolyposisAdrenocortical Carcinoma+43 more St. Jude Children's Research Hospital 1,500
Not applicableLooking for participantsNCT06523582What this trial is testingGenetic Bases of Neuroendocrine Neoplasms in Mexican PatientsWho this might be right forNeuroendocrine NeoplasmNeuroendocrine Neoplasm of Gastrointestinal TractNeuroendocrine Neoplasm of Lung+23 more Universidad Nacional Autonoma de Mexico 750
Not applicableStudy completedNCT01424878What this trial is testingStudy of Molecular Pathways in Medullary Thyroid Carcinoma and Correlation of Molecular Data With Clinical Behavior of the MTC in Individuals PatientsWho this might be right forMedullary Thyroid CarcinomaMultiple Endocrine Neoplasia Type 2 National Cancer Institute (NCI) 150
Early research (Phase 1)Study completedNCT03154086What this trial is testingA Phase 1, First Time in Human (FTIH) Study to Evaluate GSK3352589, a REarranged During Transfection (RET) Growth Factor Receptor Tyrosine Kinase Inhibitor, in Healthy VolunteersWho this might be right forIrritable Bowel Syndrome GlaxoSmithKline 68
Testing effectiveness (Phase 2)WithdrawnNCT04464967What this trial is testingSafety and Preliminary Efficacy of SNK01 in Combination With Trastuzumab or Cetuximab in Subjects With Advanced HER2 or EGFR CancersWho this might be right forAdvanced Solid TumorMetastatic CancerHER2-positive Breast Cancer+14 more NKGen Biotech, Inc.
Early research (Phase 1)Looking for participantsNCT05142189What this trial is testingClinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung CancerWho this might be right forNon-Small Cell Lung Cancer BioNTech SE 320
Early research (Phase 1)WithdrawnNCT02831179What this trial is testingVeliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine TumorWho this might be right forFunctional Pancreatic Neuroendocrine TumorMalignant SomatostatinomaMerkel Cell Carcinoma+26 more Vanderbilt-Ingram Cancer Center